SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

6 Nov 2015 07:00

RNS Number : 7856E
Tullett Prebon PLC
06 November 2015
 



6 November 2015

Tullett Prebon plc

Trading Statement

Tullett Prebon plc (the "Company") is today issuing a trading update in relation to the period from 1 July 2015.

 

Business Update

 

Our strategic review, the results of which were communicated to the market in June this year, concluded that the central role played by interdealer brokers at the heart of the global wholesale OTC markets remains secure, but that revenue declines were likely to continue in a number of traditional interdealer broker products.

 

Over the summer and through September and October the level of activity in the wholesale OTC financial markets has continued to be under pressure from the structural and cyclical factors affecting the interdealer broker industry. Market volumes continue to be adversely affected by the more onerous regulatory environment applicable to many of our bank customers whose trading activity has been suppressed by the deleveraging of their balance sheets and lower risk appetite. The continuation of low interest rate conditions and compressed bond market spreads in Europe has further dampened activity, particularly in Interest Rate Derivatives and Fixed Income products.

 

The strategic review concluded that the Energy and commodities markets do not currently face all the same pressures as the traditional interdealer broker product areas, and we have continued to benefit from the investments we have made in this sector. The performance of PVM Oil Associates Limited and its subsidiaries ("PVM"), which was acquired in November last year, has continued to be strong. PVM's main activities are in crude oil and petroleum products, and the business has continued to benefit from the level of activity in the oil and related products markets, which picked up following the significant changes in the oil price experienced since the start of the second half of 2014.

 

Revenue in the four months July to October of £255m was 9% higher than the £233m reported for the same period last year. Excluding PVM, revenue in the four months July to October was 5% lower at constant exchange rates than in the same period last year.

 

Year to date (January to October) revenue of £671m was 13% higher than the £594m reported for the same period last year. Excluding PVM, year to date revenue was 3% lower at constant exchange rates than in the same period last year.

 

We have continued to invest in the business's capabilities to identify and implement business initiatives. We have also continued to roll out our cultural, legal, compliance and risk governance frameworks to deliver our commitment to instil and embed the highest standards of conduct. As set out in our interim results announcement, these investments, increasing regulatory related costs, and the impact of the areas of business weakness, are expected to offset the improvement in the operating margin compared with that delivered last year. The further decline in revenue during the second half puts further pressure on the operating margin. The 2015 full year underlying operating profit margin is now expected to be approximately 1.5% points lower than last year.

 

In the light of the further reduction in market volumes since the end of June, particularly in Europe, further action is being taken to reduce headcount and fixed costs in the affected areas. These actions are expected to result in a reduction of around 5% in the front office headcount in the traditional interdealer product areas. The cost of these actions will be charged as an exceptional item in the 2015 accounts.

 

The Company was voted the number one interdealer broker in Currency in Risk magazine's 2015 annual interdealer rankings published in September, and was named Interest Rates Broker of the Year, and SEF of the Year, in the 2015 GlobalCapital awards.

 

The Company's financial position remains strong.

 

 

Enquiries:

 

 

Paul Mainwaring

Finance Director, Tullett Prebon plc

Direct: +44 (0)20 7200 7995

Email: pmainwaring@tullettprebon.com

 

Stephen Breslin

Group Head of Communications, Tullett Prebon plc

Direct: +44(0)20 7200 7750

Email: sbreslin@tullettprebon.com

 

Craig Breheny

Brunswick Group LLP

Direct: +44(0)20 7396 7429

Email: cbreheny@brunswickgroup.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBELLBEFFZFBB
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20262:25 pmRNSDirector/PDMR Shareholding
22nd May 202612:45 pmRNSHolding(s) in Company
13th May 20264:12 pmRNSResult of AGM
13th May 20264:12 pmRNSDirectorate change
13th May 20267:00 amRNSTrading Statement
5th May 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20269:00 amRNS2025 Annual Report and Notice of 2026 AGM
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20269:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:05 amRNSLaunch of sixth share buyback programme of £80m
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
5th Nov 20257:00 amRNSTrading Statement
2nd Oct 202510:15 amRNSDirector Declaration
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 202510:30 amRNSHolding(s) in Company
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 202510:30 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20255:50 pmRNSHolding(s) in Company
22nd Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.